Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells.
Aromatase Inhibitors
/ pharmacology
Breast Neoplasms
/ drug therapy
Cluster Analysis
Drug Resistance, Neoplasm
/ drug effects
Estrogens
/ deficiency
Exosomes
/ metabolism
Female
Gene Expression Regulation, Neoplastic
/ drug effects
Humans
MCF-7 Cells
Proteomics
Up-Regulation
/ drug effects
rab GTP-Binding Proteins
/ metabolism
Rab GTPases
breast cancer
endocrine resistance
exosomes
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
14 Aug 2020
14 Aug 2020
Historique:
received:
13
06
2020
revised:
06
08
2020
accepted:
13
08
2020
entrez:
23
8
2020
pubmed:
23
8
2020
medline:
20
2
2021
Statut:
epublish
Résumé
Aromatase inhibitors (AIs) represent the standard anti-hormonal therapy for post-menopausal estrogen receptor-positive breast cancer, but their efficacy is limited by the emergence of AI resistance (AI
Identifiants
pubmed: 32823947
pii: ijms21165841
doi: 10.3390/ijms21165841
pmc: PMC7461508
pii:
doi:
Substances chimiques
Aromatase Inhibitors
0
Estrogens
0
rab GTP-Binding Proteins
EC 3.6.5.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : MFAG #16899
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : BANDO PRIN 2017 # 2017WNKSLR_005
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG #18602
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG #21414
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : BANDO PRIN 2017 # 2017EKMFTN_001
Références
Molecules. 2018 Apr 04;23(4):
pubmed: 29617321
Exp Cell Res. 1999 Nov 1;252(2):439-48
pubmed: 10527634
Sci Rep. 2014 Jul 18;4:5750
pubmed: 25034888
DNA Repair (Amst). 2017 Mar;51:20-30
pubmed: 28108275
Cancer Res. 2018 Sep 15;78(18):5287-5299
pubmed: 30042153
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Cancer Cell. 2014 Nov 10;26(5):707-21
pubmed: 25446899
Blood. 2005 Feb 15;105(4):1734-41
pubmed: 15494427
Cancer Cell. 2014 Nov 10;26(5):754-69
pubmed: 25446900
Oncogene. 2018 Jul;37(28):3806-3821
pubmed: 29636548
Anal Chem. 2003 Feb 1;75(3):663-70
pubmed: 12585499
Int J Cancer. 2013 May 15;132(10):2237-47
pubmed: 23124354
Semin Cancer Biol. 2015 Apr;31:3-15
pubmed: 24912116
Cell Death Dis. 2020 Jan 22;11(1):43
pubmed: 31969559
Breast Cancer Res. 2014 Jun 11;16(3):R62
pubmed: 24919951
Pharmacol Ther. 2018 Aug;188:1-11
pubmed: 29476772
Cancer Res. 2012 Oct 1;72(19):4920-30
pubmed: 22865453
Nat Cell Biol. 2010 Jan;12(1):19-30; sup pp 1-13
pubmed: 19966785
Stem Cells. 2014 Apr;32(4):983-97
pubmed: 24715691
Endocr Relat Cancer. 2011 Apr 28;18(3):333-45
pubmed: 21367843
BMC Cancer. 2014 Mar 12;14:176
pubmed: 24620748
CNS Neurosci Ther. 2014 Feb;20(2):112-8
pubmed: 24279471
OMICS. 2011 Jun;15(6):347-52
pubmed: 21332390
Eur Rev Med Pharmacol Sci. 2016 Oct;20(20):4362-4368
pubmed: 27831634
Cancer Cell. 2016 Aug 8;30(2):189-191
pubmed: 27505667
Oncoimmunology. 2017 Aug 11;6(12):e1362530
pubmed: 29209569
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Cancer Sci. 2011 Dec;102(12):2172-8
pubmed: 21895870
Nat Methods. 2014 Mar;11(3):319-24
pubmed: 24487582
Cell Rep. 2015 Apr 7;11(1):111-24
pubmed: 25818297
Int J Oncol. 2012 Jan;40(1):130-8
pubmed: 21904773
J Biomed Sci. 2016 Oct 6;23(1):70
pubmed: 27716280
Tumour Biol. 2014 Nov;35(11):10773-9
pubmed: 25077924
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4852-7
pubmed: 21368175
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S75-84
pubmed: 16113101
Cancer Res. 2005 May 1;65(9):3903-10
pubmed: 15867390
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Elife. 2017 Dec 18;6:
pubmed: 29251598
Int J Oncol. 2018 Sep;53(3):1013-1026
pubmed: 30015837
Oncotarget. 2015 Aug 28;6(25):20813-28
pubmed: 26308575
J Clin Med. 2019 Jul 12;8(7):
pubmed: 31336913
Oncogene. 2010 Apr 22;29(16):2404-14
pubmed: 20101208
Biochim Biophys Acta. 2015 Nov;1850(11):2185-95
pubmed: 26272430
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9066-E9075
pubmed: 29073103
J Cell Biol. 2014 Jul 21;206(2):307-28
pubmed: 25049275
J Biol Chem. 2010 Feb 19;285(8):5581-93
pubmed: 20026603
Breast Cancer Res Treat. 2019 Nov;178(1):57-62
pubmed: 31346846
Front Immunol. 2017 Sep 22;8:1174
pubmed: 29018443
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Endocr Relat Cancer. 2016 Aug;23(8):R337-52
pubmed: 27406875
Biochem Soc Trans. 2012 Dec 1;40(6):1398-403
pubmed: 23176488
PLoS One. 2014 May 15;9(5):e97580
pubmed: 24831807
Mol Cancer. 2019 Mar 30;18(1):58
pubmed: 30925921
Cancer Res. 2005 Apr 1;65(7):2761-9
pubmed: 15805276
Biosci Rep. 2019 Feb 5;39(2):
pubmed: 29769411
Breast Cancer Res Treat. 2014 Sep;147(2):423-31
pubmed: 25007959
Nat Rev Cancer. 2015 May;15(5):261-75
pubmed: 25907219
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Oncotarget. 2016 Sep 13;7(37):59173-59188
pubmed: 27385095
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S61-73
pubmed: 16113100
Onco Targets Ther. 2018 Nov 05;11:7805-7820
pubmed: 30464528
Small GTPases. 2018 Mar 4;9(1-2):95-106
pubmed: 28135905
J Mol Biol. 2001 Nov 2;313(4):889-901
pubmed: 11697911
Pharm Res. 2012 Mar;29(3):643-50
pubmed: 21969054